为明天的健康做投资

 

梅里埃发展基金是一家专业的私募股权基金公司,其投资和经营的公司在全球健康和营养领域开发了顶尖的产品和服务。2014年, 梅里埃集团共实现营业额20亿欧元。集团下属子公司包括生物梅里埃(体外诊断),梅里埃营养科学(食品安全及营养学研究外包服务),Transgene(免疫疗法),和Advanced BioScience LaboratoriesCRO/CMO)。

 

 

四大投资领域

在选定的四个投资领域内,梅里埃发展基金选择那些经营业务对健康和营养领域具有重要影响力的公司,并资助资助其高附加值产品和服务的开发和商业拓展。

体外诊断

分子诊断、临床诊断/快速检测、临床和工业微生物、临床生物标记、数据管理和数据分析

医学设备

影像系统及试剂、微创手术器械、眼科医疗器械、生物材料、病人管理以及监测相关软件系统

医疗服务

家庭护理、高强度护理、病人管理以及对于慢性、遗传性疾病病人的特别护理

 

预防医学和营养学

抗感染药剂及疫苗、基因营养学工具和服务和经临床试验验证的营养保健品

 

企业家有话说

  • "梅里埃发展基金的团队非常积极得参与公司的战略决策,同时又非常尊重我们的管理团队。他们不仅善于维持好与企业的关系,而且很好得帮助公司实现了战略扩张。"
    Eric MOTTAY
    Amplitude
  • "运用他们的智慧和洞察力,梅里埃发展基金给我们提供了资金之外更重要的资产 - 他们和我们分享战略定位、项目开发及产品商业化方面的丰富经验,帮助其投资组合内的公司更好得成功。他们对行业外来发展有着敏锐的预期,能够帮助企业更快更好得实现所指定的目标。与梅里埃发展基金合作是一次共赢,我们共同推动医疗保健的未来发展。"
    Emily LEPROUST
    Twist
  • "我非常高兴亚历山大梅里埃能够加入我们的董事会。他们家族长期致力于人类和动物保健事业,有着强大的工业基础和长远的发展眼光,他们给我们带来了意想不到的价值。"
    Marc PRIKAZSKY
    Ceva
  • "We are thrilled by the opportunity of working together with Mérieux Développement, whose industrial experience and global healthcare network will be extremely valuable in helping us to achieve our goal of becoming a market leader in the OSA device segment."
    Alex RAPOPORT
    keepMed
  • "The very promising clinical results generated with the Simeox™ solution in the last two years naturally lead us to expand internationally for further clinical investigation and commercial development. Our goal is to make PhysioAssist the international market standard for the treatment of chronic respiratory diseases. With this ambition in mind, the selection of our strong financial partners is a key success factor. We are pleased and proud to have Mérieux Développement and Turenne Capital as new shareholders. "
    Adrien MITHALAL
    PhysioAssist
  • "We warmly welcome Merieux Developpement to our multinational syndicate of valued investors, With well-earned reputations for deep diligence and a commitment to their portfolio companies, we couldn't ask for better partners for this next exciting stage of our company's evolution. "
    David VAN METER
    Ivantis
  • "The Natural Health market is estimated at 11 billion €uros and currently represents more than 200 companies in Europe. Our decision to partner with Mérieux Développement, as a new reference shareholder of Ineldea Laboratories, is clearly in line with our desire to boost our presencein this fast growing market, through organic growth and acquisition. We are delighted that Mérieux Développement, a renowned and investor with strong expertise in our sector, supports us to get to the next stage of our company journey."
    Nicolas CAPPELAERE
    Ineldea

我们投资的企业

自2010年以来,梅里埃发展基金共投资了12家企业,从初创型企业到在市场上已经取得稳固地位的扩展期企业,典型案例包括:

(Mutzig, FRANCE)
(Pessac, FRANCE)
(PESSAC, France)
(Saint Priest, FRANCE)
(Inglewood, USA)
(Carros, FRANCE)
(Irvine, USA)
(Campbell, USA)
(Rishon Le Zion, ISRAEL)
(Venissieux, FRANCE)
(Luxembourg, LUXEMBOURG)
(Vertou, FRANCE)
(Lyon, FRANCE)
(Rockville, USA)
(Aix-en-Provence, FRANCE)
(Cambridge, USA)
(Pleasenton, USA)
(Aix en Provence, FRANCE)
(Oulu, FINLANDE)
(Austin, USA)
梅里埃集团的全球商业资源